FDA-Inspected Site

Kappa Laboratories, Inc.

3 FDA inspections are on record for Kappa Laboratories, Inc. in Miami, United States.

483· Form 483 issued

Miami, United States · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-06-04.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
19 May 2025 – 4 Jun 2025Human Drugs483View 483 →
20 Apr 2022 – 22 Apr 2022Human Drugs483View 483 →
23 Aug 2017 – 25 Aug 2017Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Jun 2025
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Jennifer Lalama, Mickell Smith

4 Jun 2025
21 CFR 211.192

No written record of investigation

Cited by Jennifer Lalama, Mickell Smith

4 Jun 2025
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Jennifer Lalama, Mickell Smith

22 Apr 2022
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Joanne E King, Kayla V Sprague

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Kappa Laboratories, Inc.'s 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat